cBHRT Compounding and the Risks to Patient and Provider Access

<p>The FDA is signaling that it may consider new restrictions on compounded hormones based on a flawed and biased report it commissioned. Help ensure access to compounded Bio-Identical hormones, visit compounding.com for more information. Take Action! Contact members of Congress: https://compounding.com/findmyrep Share your Story: https://compounding.com/testimonials http://www.medshoprx.com</p>